Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
25
TBN Quote, Financials, Valuation and Earnings
Last price:
$16.90
Seasonality move
:
--
Day range:
$16.15 - $17.25
52-week range:
$15.75 - $25.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.89x
Volume:
5.6K
Avg. volume:
11.8K
1-year change:
--
Market cap:
$245.4M
Revenue:
--
EPS (TTM):
--
Earnings Data
Next earnings date for TBN
Jan 30
2025
Most recent earnings per share
-$0.42
Beat by $0.02
(Nov 12/2024)
Consensus Estimate
-$0.43
(Nov 12/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TBN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 01/30/2025 | Q4 | -- | -- | -- | -$0.47 | -- |
| 11/12/2024 | Q3 | -- | -- | -$0.42 | -$0.43 | $0.02 |
| 09/20/2024 | Q2 | -- | -- | -- | -$0.72 | -- |
| 12/31/2023 | Q4 | -- | -- | -$0.00 | -- | -- |
Tamboran Resources Earnings Questions
-
How Much did Tamboran Resources Generate in Revenue Last Quarter?
Tamboran Resources reported -- worth of top line sales in its most recent quarter.
-
Did Tamboran Resources Beat Earnings Last Quarter?
Tamboran Resources announced earnings per share of -$0.42 which represents a beat of analyst forecast a -$0.43 per share.
-
Is Tamboran Resources Profitable?
Tamboran Resources reported -$30.7K that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for Tamboran Resources EPS Next Year?
Tamboran Resources's earnings are forecast to decrease from -$2.32 per share to -$1.58 per share next year representing a decrease of -12.46%.
-
When is Tamboran Resources's Earnings Date?
Tamboran Resources's next earnings date is January 30, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 1.47% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 10% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 1.24% over the past day.
